Not yet recruiting
Bronchopulmonary aspergillosis
Not yet recruitingStudy of inhaled liposomal amphotericin B and technetium-99m to assess lung distribution in patients with chronic pulmonary aspergillosis
Registered drugNo placebo
Study of inhaled liposomal amphotericin B and technetium-99m to assess lung distribution in patients with chronic pulmonary aspergillosis
Registered drugNo placebo
- Disease:Bronchopulmonary aspergillosis
- Substances:Amphotericin BTechnetium (99MTC) pertechnetate
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Amphotericin B
